FDA.reportPublic FDA data

neomycin 3.5 MG/ML / triamcinolone acetonide 1 MG/ML Otic Solution

RxCUI
1086278
RxNorm name
neomycin 3.5 MG/ML / triamcinolone acetonide 1 MG/ML Otic Solution
Term type
SCD
Status
Active
Updated
2026-06-14 07:05:41

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
022011
Active start
022011
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
triamcinolone acetonide1 MG / 1 MLtriamcinolonetriamcinolone acetonide
neomycin sulfate3.5 MG / 1 MLneomycinneomycin

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Otic Solution316973

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
triamcinolone10759
neomycin7299

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
RXNAV_STRneomycin 3.5 MG/ML / triamcinolone acetonide 1 MG/ML Otic SolutionNAMES
RxNorm Nameneomycin 3.5 MG/ML / triamcinolone acetonide 1 MG/ML Otic SolutionNAMES
RxNorm Synonymneomycin 0.35 % / triamcinolone acetonide 0.1 % Otic DropsNAMES
TTYSCDATTRIBUTES
RxCUI1086278CODES

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCS01AAAntibioticsATC1-4neomycin
ATCR02ABAntibioticsATC1-4neomycin
ATCA07AAAntibioticsATC1-4neomycin
ATCS03AAAntiinfectivesATC1-4neomycin
ATCS02AAAntiinfectivesATC1-4neomycin
ATCB05CAAntiinfectivesATC1-4neomycin
ATCA01ABAntiinfectives and antiseptics for local oral treatmentATC1-4neomycin
ATCC05AACorticosteroidsATC1-4triamcinolone
ATCR01ADCorticosteroidsATC1-4triamcinolone
ATCA01ACCorticosteroids for local oral treatmentATC1-4triamcinolone
ATCD07ABCorticosteroids, moderately potent (group II)ATC1-4triamcinolone
ATCD07XBCorticosteroids, moderately potent, other combinationsATC1-4triamcinolone
ATCS01BACorticosteroids, plainATC1-4triamcinolone
ATCR03BAGlucocorticoidsATC1-4triamcinolone
ATCH02ABGlucocorticoidsATC1-4triamcinolone
ATCJ01GBOther aminoglycosidesATC1-4neomycin
ATCD06AXOther antibiotics for topical useATC1-4neomycin
FDASPLD000617AminoglycosidesCHEMhas_chemical_structureneomycin
FDASPLN0000175477Aminoglycoside AntibacterialEPChas_epcneomycin
FDASPLN0000175576CorticosteroidEPChas_epctriamcinolone acetonide
FDASPLN0000175576CorticosteroidEPChas_epctriamcinolone
FDASPLN0000175450Corticosteroid Hormone Receptor AgonistsMOAhas_moatriamcinolone
FDASPLN0000175450Corticosteroid Hormone Receptor AgonistsMOAhas_moatriamcinolone acetonide
MEDRTD009355NeomycinCHEMhas_ingredientneomycin
MEDRTD014221TriamcinoloneCHEMhas_ingredienttriamcinolone
MEDRTD014222Triamcinolone AcetonideCHEMhas_ingredienttriamcinolone acetonide
MEDRTD000309Adrenal InsufficiencyDISEASEmay_treattriamcinolone acetonide
MEDRTD000309Adrenal InsufficiencyDISEASEmay_treattriamcinolone
MEDRTD000743Anemia, HemolyticDISEASEmay_treattriamcinolone acetonide
MEDRTD000743Anemia, HemolyticDISEASEmay_treattriamcinolone
MEDRTD015210Arthritis, GoutyDISEASEmay_preventtriamcinolone
MEDRTD015210Arthritis, GoutyDISEASEmay_preventtriamcinolone acetonide
MEDRTD001172Arthritis, RheumatoidDISEASEmay_preventtriamcinolone
MEDRTD001172Arthritis, RheumatoidDISEASEmay_preventtriamcinolone acetonide
MEDRTD001249AsthmaDISEASEmay_preventtriamcinolone
MEDRTD001249AsthmaDISEASEmay_preventtriamcinolone acetonide
MEDRTD001424Bacterial InfectionsDISEASEmay_preventneomycin
MEDRTD001607BerylliosisDISEASEmay_treattriamcinolone acetonide
MEDRTD001607BerylliosisDISEASEmay_treattriamcinolone
MEDRTD001986Bronchial SpasmDISEASEmay_treattriamcinolone
MEDRTD001986Bronchial SpasmDISEASEmay_treattriamcinolone acetonide
MEDRTD003093Colitis, UlcerativeDISEASEmay_treattriamcinolone
MEDRTD003093Colitis, UlcerativeDISEASEmay_treattriamcinolone acetonide
MEDRTD003874Dermatitis HerpetiformisDISEASEmay_treattriamcinolone
MEDRTD003874Dermatitis HerpetiformisDISEASEmay_treattriamcinolone acetonide
MEDRTD003876Dermatitis, AtopicDISEASEmay_treattriamcinolone acetonide
MEDRTD003876Dermatitis, AtopicDISEASEmay_treattriamcinolone
MEDRTD004342Drug HypersensitivityDISEASEci_withtriamcinolone acetonide
MEDRTD004342Drug HypersensitivityDISEASEci_withtriamcinolone
MEDRTD004342Drug HypersensitivityDISEASEci_withneomycin
MEDRTD004892Erythema MultiformeDISEASEmay_treattriamcinolone
MEDRTD004892Erythema MultiformeDISEASEmay_treattriamcinolone acetonide
MEDRTD004927Escherichia coli InfectionsDISEASEmay_treatneomycin
MEDRTD005148Facial DermatosesDISEASEmay_treattriamcinolone
MEDRTD005148Facial DermatosesDISEASEmay_treattriamcinolone acetonide
MEDRTD005533Foot DermatosesDISEASEmay_treattriamcinolone acetonide
MEDRTD005533Foot DermatosesDISEASEmay_treattriamcinolone
MEDRTD006229Hand DermatosesDISEASEmay_treattriamcinolone
MEDRTD006229Hand DermatosesDISEASEmay_treattriamcinolone acetonide
MEDRTD006501Hepatic EncephalopathyDISEASEmay_treatneomycin
MEDRTD006934HypercalcemiaDISEASEmay_treattriamcinolone acetonide
MEDRTD006934HypercalcemiaDISEASEmay_treattriamcinolone
MEDRTD007239InfectionsDISEASEci_withtriamcinolone acetonide
MEDRTD007239InfectionsDISEASEci_withtriamcinolone
MEDRTD007249InflammationDISEASEmay_treattriamcinolone acetonide
MEDRTD007249InflammationDISEASEmay_treattriamcinolone
MEDRTD015212Inflammatory Bowel DiseasesDISEASEci_withneomycin
MEDRTD007415Intestinal ObstructionDISEASEci_withneomycin
MEDRTD007868Leg DermatosesDISEASEmay_treattriamcinolone acetonide
MEDRTD007868Leg DermatosesDISEASEmay_treattriamcinolone
MEDRTD008180Lupus Erythematosus, SystemicDISEASEmay_treattriamcinolone acetonide
MEDRTD008180Lupus Erythematosus, SystemicDISEASEmay_treattriamcinolone
MEDRTD009103Multiple SclerosisDISEASEmay_treattriamcinolone
MEDRTD009103Multiple SclerosisDISEASEmay_treattriamcinolone acetonide
MEDRTD009181MycosesDISEASEci_withtriamcinolone
MEDRTD009181MycosesDISEASEci_withtriamcinolone acetonide
MEDRTD009404Nephrotic SyndromeDISEASEmay_treattriamcinolone acetonide
MEDRTD009404Nephrotic SyndromeDISEASEmay_treattriamcinolone
MEDRTD010392PemphigusDISEASEmay_treattriamcinolone
MEDRTD010392PemphigusDISEASEmay_treattriamcinolone acetonide
MEDRTD012216Rheumatic DiseasesDISEASEmay_treattriamcinolone acetonide
MEDRTD012216Rheumatic DiseasesDISEASEmay_treattriamcinolone
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treattriamcinolone
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treattriamcinolone acetonide
MEDRTD012536Scalp DermatosesDISEASEmay_treattriamcinolone acetonide
MEDRTD012536Scalp DermatosesDISEASEmay_treattriamcinolone
MEDRTD012713Serum SicknessDISEASEmay_treattriamcinolone
MEDRTD012713Serum SicknessDISEASEmay_treattriamcinolone acetonide
MEDRTD017192Skin Diseases, BacterialDISEASEmay_treatneomycin
MEDRTD013167Spondylitis, AnkylosingDISEASEmay_treattriamcinolone acetonide
MEDRTD013167Spondylitis, AnkylosingDISEASEmay_treattriamcinolone
MEDRTD013224Status AsthmaticusDISEASEci_withtriamcinolone
MEDRTD013224Status AsthmaticusDISEASEci_withtriamcinolone acetonide
MEDRTD013585SynovitisDISEASEmay_treattriamcinolone acetonide
MEDRTD013585SynovitisDISEASEmay_treattriamcinolone
MEDRTD013966ThyroiditisDISEASEmay_treattriamcinolone
MEDRTD013966ThyroiditisDISEASEmay_treattriamcinolone acetonide
MEDRTD014397Tuberculosis, PulmonaryDISEASEmay_treattriamcinolone acetonide
MEDRTD014397Tuberculosis, PulmonaryDISEASEmay_treattriamcinolone
MEDRTD014605UveitisDISEASEmay_treattriamcinolone
MEDRTD014605UveitisDISEASEmay_treattriamcinolone acetonide
MEDRTN0000000159Glucocorticoid Receptor AgonistsMOAhas_moatriamcinolone acetonide
MEDRTN0000000159Glucocorticoid Receptor AgonistsMOAhas_moatriamcinolone
MEDRTN0000000134Lipoxygenase InhibitorsMOAhas_moatriamcinolone
MEDRTN0000000134Lipoxygenase InhibitorsMOAhas_moatriamcinolone acetonide
MEDRTN0000000150Protein Synthesis InhibitorsMOAhas_moaneomycin
MEDRTN0000008327Carbohydrate Metabolism AlterationPEhas_petriamcinolone acetonide
MEDRTN0000008327Carbohydrate Metabolism AlterationPEhas_petriamcinolone
MEDRTN0000010253Decreased Capillary PermeabilityPEhas_petriamcinolone
MEDRTN0000010253Decreased Capillary PermeabilityPEhas_petriamcinolone acetonide
MEDRTN0000008571Decreased Cytokine ActivityPEhas_petriamcinolone acetonide
MEDRTN0000008571Decreased Cytokine ActivityPEhas_petriamcinolone
MEDRTN0000010248Decreased Fibroblast MigrationPEhas_petriamcinolone
MEDRTN0000010248Decreased Fibroblast MigrationPEhas_petriamcinolone acetonide
MEDRTN0000008645Decreased Glucocorticoid SecretionPEhas_petriamcinolone acetonide
MEDRTN0000008645Decreased Glucocorticoid SecretionPEhas_petriamcinolone
MEDRTN0000008681Decreased Leukotriene ActivityPEhas_petriamcinolone
MEDRTN0000008681Decreased Leukotriene ActivityPEhas_petriamcinolone acetonide
MEDRTN0000010246Decreased Polymorphonuclear Leukocyte MigrationPEhas_petriamcinolone acetonide
MEDRTN0000010246Decreased Polymorphonuclear Leukocyte MigrationPEhas_petriamcinolone

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESTTYSCD
CODESRxCUI1086278
CODESSNOMEDCT330973003
NAMESPrescribable Synonymneomycin 0.35 % / triamcinolone acetonide 0.1 % Otic Drops
NAMESRXNAV_STRneomycin 3.5 MG/ML / triamcinolone acetonide 1 MG/ML Otic Solution
NAMESRxNorm Nameneomycin 3.5 MG/ML / triamcinolone acetonide 1 MG/ML Otic Solution
NAMESRxNorm Synonymneomycin 0.35 % / triamcinolone acetonide 0.1 % Otic Drops
SOURCESSourceUS Edition of SNOMED_CT